• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病治疗的新方法

New Approaches to the Treatment of Alzheimer's Disease.

作者信息

Kruk-Słomka Marta, Kuceł Dominika, Małysz Maria, Machnikowska Adrianna, Orzelska-Górka Jolanta, Biała Grażyna

机构信息

Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.

出版信息

Pharmaceuticals (Basel). 2025 Jul 26;18(8):1117. doi: 10.3390/ph18081117.

DOI:10.3390/ph18081117
PMID:40872509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389568/
Abstract

Alzheimer's disease (AD) is one of the most common chronic neurodegenerative disorders worldwide. It is characterized by progressive memory loss and cognitive decline, leading to dementia. The pathogenesis of the disease is primarily attributed to two pathological protein structures: amyloid-beta (Aβ) plaques and tau protein neurofibrils. The current treatment strategies for AD are mainly symptomatic, highlighting the urgent need for the development of new, more effective therapies for the disease. The purpose of this paper is to provide a comprehensive and scientific review of the latest research regarding novel therapeutic options in the treatment of AD. In recent years, research has focused on more advanced and diversified strategies, including immunotherapy, gene therapy, tyrosine kinase inhibitors, therapies targeting mitochondrial function, and neurogenesis-related process modulation. One of the most promising treatment strategies for AD is immunotherapy. Intensive research is currently underway on both passive immunization, which involves the administration of monoclonal antibodies, and active immunization through vaccinations that stimulate the body to produce specific antibodies. Further research into novel therapeutic directions is essential, particularly concerning the role of the immune system in the pathogenesis of AD. Immunization appears to be a highly promising approach to developing effective methods for preventing AD or delaying the progression of this disease.

摘要

阿尔茨海默病(AD)是全球最常见的慢性神经退行性疾病之一。其特征是进行性记忆丧失和认知衰退,最终导致痴呆。该疾病的发病机制主要归因于两种病理性蛋白质结构:β-淀粉样蛋白(Aβ)斑块和tau蛋白神经原纤维。目前AD的治疗策略主要是对症治疗,这凸显了迫切需要开发新的、更有效的治疗方法。本文的目的是对AD治疗中新型治疗选择的最新研究进行全面而科学的综述。近年来,研究集中在更先进和多样化的策略上,包括免疫疗法、基因疗法、酪氨酸激酶抑制剂、针对线粒体功能的疗法以及与神经发生相关过程的调节。AD最有前景的治疗策略之一是免疫疗法。目前正在对被动免疫(即注射单克隆抗体)和通过疫苗接种进行的主动免疫(刺激机体产生特异性抗体)进行深入研究。进一步探索新型治疗方向至关重要,特别是关于免疫系统在AD发病机制中的作用。免疫疗法似乎是开发预防AD或延缓其疾病进展的有效方法的极具前景的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e0/12389568/9bd61c7e4e41/pharmaceuticals-18-01117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e0/12389568/e4a59fb1203e/pharmaceuticals-18-01117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e0/12389568/9bd61c7e4e41/pharmaceuticals-18-01117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e0/12389568/e4a59fb1203e/pharmaceuticals-18-01117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e0/12389568/9bd61c7e4e41/pharmaceuticals-18-01117-g002.jpg

相似文献

1
New Approaches to the Treatment of Alzheimer's Disease.阿尔茨海默病治疗的新方法
Pharmaceuticals (Basel). 2025 Jul 26;18(8):1117. doi: 10.3390/ph18081117.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.阿尔茨海默病运动功能障碍检测与管理的最新进展
Psychiatriki. 2025 May 14. doi: 10.22365/jpsych.2025.012.
4
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
7
A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease.抗淀粉样蛋白β单克隆抗体治疗阿尔茨海默病的疗效和安全性的系统评价。
Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12.
8
Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.老年言语变化:基于言语的健康衰老与阿尔茨海默病鉴别方法学的考虑。
Int J Lang Commun Disord. 2024 Jan-Feb;59(1):13-37. doi: 10.1111/1460-6984.12888. Epub 2023 May 4.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Active Immunization Targeting Amyloid β for the Treatment of Alzheimer's Disease.靶向淀粉样β蛋白的主动免疫疗法治疗阿尔茨海默病
Neurodegener Dis. 2025 May 10:1-16. doi: 10.1159/000546287.

本文引用的文献

1
Revealing the potential therapeutic mechanism of in Alzheimer's disease: a computational biology approach.揭示[具体药物或疗法名称未给出]在阿尔茨海默病中的潜在治疗机制:一种计算生物学方法。
Front Med (Lausanne). 2024 Nov 13;11:1468561. doi: 10.3389/fmed.2024.1468561. eCollection 2024.
2
Recent Advances in Therapeutics for the Treatment of Alzheimer's Disease.治疗阿尔茨海默病的治疗方法的最新进展。
Molecules. 2024 Oct 30;29(21):5131. doi: 10.3390/molecules29215131.
3
Growth Factor Gene Therapy for Alzheimer's Disease.生长因子基因治疗阿尔茨海默病。
J Alzheimers Dis. 2024;101(s1):S433-S441. doi: 10.3233/JAD-240545.
4
A promising therapeutic: Exosome-mediated mitochondrial transplantation.一种有前途的治疗方法:外泌体介导的线粒体移植。
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113104. doi: 10.1016/j.intimp.2024.113104. Epub 2024 Sep 12.
5
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.阿尔茨海默病的最新进展:机制、临床试验和新药研发策略。
Signal Transduct Target Ther. 2024 Aug 23;9(1):211. doi: 10.1038/s41392-024-01911-3.
6
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.载脂蛋白 E 与痴呆症研究进展:2023 年阿尔茨海默病协会国际会议(AAIC)载脂蛋白 E 会议要点
Alzheimers Dement. 2024 Sep;20(9):6590-6605. doi: 10.1002/alz.13877. Epub 2024 Jul 19.
7
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.tau 蛋白聚集之谜:机制见解与未来挑战。
Int J Mol Sci. 2024 May 2;25(9):4969. doi: 10.3390/ijms25094969.
8
Dual Drug Repurposing: The Example of Saracatinib.双重药物再利用:以萨拉替尼为例。
Int J Mol Sci. 2024 Apr 22;25(8):4565. doi: 10.3390/ijms25084565.
9
CoQ and Mitochondrial Dysfunction in Alzheimer's Disease.辅酶Q与阿尔茨海默病中的线粒体功能障碍
Antioxidants (Basel). 2024 Feb 2;13(2):191. doi: 10.3390/antiox13020191.
10
Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management.阿尔茨海默病的现有疗法、新型药物传递系统以及更好疾病管理的未来方向。
J Control Release. 2024 Mar;367:402-424. doi: 10.1016/j.jconrel.2024.01.047. Epub 2024 Feb 1.